Holt Capital Advisors L.L.C. dba Holt Capital Partners L.P. Cuts Stake in iShares Biotechnology ETF $IBB

Holt Capital Advisors L.L.C. dba Holt Capital Partners L.P. decreased its position in iShares Biotechnology ETF (NASDAQ:IBB) by 68.1% during the 2nd quarter, Holdings Channel reports. The fund owned 2,965 shares of the financial services provider’s stock after selling 6,330 shares during the quarter. Holt Capital Advisors L.L.C. dba Holt Capital Partners L.P.’s holdings in iShares Biotechnology ETF were worth $375,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Citigroup Inc. lifted its position in iShares Biotechnology ETF by 27.0% in the second quarter. Citigroup Inc. now owns 4,073,967 shares of the financial services provider’s stock valued at $515,398,000 after purchasing an additional 865,823 shares during the period. JPMorgan Chase & Co. lifted its holdings in iShares Biotechnology ETF by 74.2% in the second quarter. JPMorgan Chase & Co. now owns 833,196 shares of the financial services provider’s stock valued at $105,408,000 after acquiring an additional 355,000 shares during the period. Bronte Capital Management Pty Ltd. boosted its position in shares of iShares Biotechnology ETF by 12.6% during the 2nd quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock worth $37,000 after purchasing an additional 32,947 shares in the last quarter. Employees Retirement System of Texas acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter worth $25,049,000. Finally, Jones Financial Companies Lllp increased its holdings in shares of iShares Biotechnology ETF by 763.3% in the 1st quarter. Jones Financial Companies Lllp now owns 151,265 shares of the financial services provider’s stock valued at $19,347,000 after purchasing an additional 133,744 shares in the last quarter. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 0.5%

Shares of NASDAQ IBB opened at $169.42 on Friday. The firm has a 50-day moving average price of $161.58 and a 200 day moving average price of $143.61. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $174.40.

iShares Biotechnology ETF Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were issued a $0.0828 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $0.33 dividend on an annualized basis and a dividend yield of 0.2%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.